COVID-19 Research Paper Volume 14, Issue 2 pp 557—571

Association between tocilizumab treatment and clinical outcomes of COVID-19 patients: a systematic review and meta-analysis


Figure 1. Association of tocilizumab with all-cause mortality, discharge, patients of adverse events, and date of incubation or death in the published study and preprint study (A) all-cause mortality (B) discharge (C) patients of adverse events (D) date of incubation or death.